NAD+ IV for Fatigue and Brain Fog: Who It Helps and Who It Does Not

You wake up tired. Your coffee stops working by 10 AM. Your focus drifts by early afternoon. No amount of sleep seems to reset it.

That combination is the single most common reason people come to see me. It is also the one where the temptation to jump straight to a drip is strongest, and where doing so is most likely to waste your money. So let us take it in order.

Before NAD+: What Has to Be Ruled Out First

Fatigue and brain fog are symptoms, not diagnoses, and several very treatable things produce exactly this picture. Working through them first is not a delaying tactic. It is the part that most often finds the answer.

• Thyroid function. Subclinical hypothyroidism affects a meaningful share of adults, and middle-aged patients with it may have fatigue, altered mood and cognitive symptoms (Biondi, Cappola and Cooper, JAMA, DOI: 10.1001/jama.2019.9052, PMID 31287527).
• Iron and B12 status. Ferritin can be low enough to cause symptoms while haemoglobin still looks normal, which is why a standard anaemia screen alone can miss it.
• The menopause transition. Disrupted sleep, mood fluctuation and cognitive changes are recognised features, and the link to menopause is often not obvious to the person experiencing it (Duralde, Sobel and Manson, BMJ, DOI: 10.1136/bmj-2022-072612, PMID 37553173).
• Sleep quality, not just sleep hours. Untreated sleep apnoea is common and frequently missed in people who do not fit the stereotype.
• Blood sugar, medications, alcohol, mood and stress load. Each of these can produce the same two symptoms on its own.

If one of these is driving how you feel, an infusion will not fix it, and I would rather tell you that at the consultation than after you have paid for a series.

Where NAD+ Actually Comes In

NAD+ is a coenzyme found in every cell of your body. It is central to ATP production, the process your mitochondria use to generate usable energy. It also supports sirtuins, a family of proteins involved in DNA repair and inflammation control, and fuels PARP enzymes, the cell's DNA damage-response system. The available pool declines with age, and we cover why in detail in why NAD+ declines with age.

The relevance to fatigue and fog is mechanistic and plausible: a cell with a smaller energy budget does less work, and the two tissues that notice first tend to be muscle and brain. That is the reasoning. It is worth being clear that reasoning is not the same as proof, and the human trial evidence here is thinner than most clinics admit. We lay that out plainly in does NAD+ IV therapy actually work.

What People Describe After an Infusion

Steadier energy rather than a spike

The description patients give most often is not a lift like caffeine. It is the absence of the crash: the two o'clock wall arriving later, or not at all. People frequently describe it as their floor being raised rather than their ceiling. That pattern shows up most in people whose fatigue is not resolving with rest, who are recovering from an illness, or who train hard and are not bouncing back the way they used to.

Clearer thinking

The cognitive change people report is usually described as fog lifting: sentences finishing more easily, less effort to hold a thread, faster recall of the word they wanted. For people whose work depends on sustained mental output, this is often the effect that matters most to them.

I want to be careful here. NAD+ has not been shown to treat or prevent cognitive disease, and I do not offer it for that. What is being described is a shift in day-to-day mental stamina, reported by patients, not a measured cognitive outcome from a large trial.

Burnout and nervous system load

Prolonged stress is not only psychological. It changes sleep, appetite, metabolic function and how much energy demand your system is carrying. Patients recovering from a long high-stress period, or from post-viral fatigue, often use a short NAD+ series as one component of a broader recovery plan that also addresses sleep, hormones and workload. It works better as part of that plan than as a substitute for it.

Where it fits with metabolic and hormone care

NAD+ is involved in insulin sensitivity and fat and glucose metabolism, and it is often used alongside hormone optimization or a medical weight programme. It is not a weight loss treatment and I would not sell it as one. What patients do report is that when energy improves, the parts of a plan that require effort become more sustainable.

What NAD+ Will Not Do

An honest list is more useful than a long benefits list.

• It will not replace a hormone you are genuinely low in.
• It will not correct low iron, low B12 or a thyroid problem.
• It will not treat sleep apnoea, depression or an anxiety disorder.
• It will not cause weight loss on its own.
• It is not a treatment for any neurological or cognitive disease.
• It is not a guarantee of feeling different, and some people notice nothing.

If a clinic tells you otherwise, that is a reason to be more careful, not less.

Practical Questions

How soon would I know if it is helping?

Most people who respond notice something within 24 to 72 hours of the first infusion. If a short initial series produces nothing at all, that is useful information, and the right response is to stop and look harder at the underlying cause rather than to keep buying sessions.

How often would I need it?

For fatigue or burnout recovery specifically, a short series of a few sessions over a few weeks is the usual starting point, followed by spacing out or stopping based on how you respond. Dosing, session length and pricing are covered in our main NAD+ IV therapy guide.

Could I just take a pill instead?

Possibly, and the oral evidence is genuinely stronger than the IV evidence. Oral precursors act as a slow daily baseline rather than a fast push. We compare them in NMN vs NR, which precursor actually reaches your cells.

Who should not have it?

A clinical assessment comes first for everyone. NAD+ IV is generally not appropriate, or needs specialist clearance, for people who are pregnant or breastfeeding, in active cancer treatment, or who have significant kidney, liver or cardiac disease, uncontrolled hypertension, or known sensitivity to nicotinamide. This is not a complete list; we decide together based on your history.

What are the side effects?

The common ones are rate-dependent: mild chest tightness, abdominal cramping, nausea, flushing or a brief headache while the drip runs quickly. They typically ease within minutes of slowing the infusion, which is why the rate is adjusted throughout the session rather than set once at the start.

Is NAD+ the same as vitamin B3?

They are related but not the same. Your body makes NAD+ from vitamin B3 (niacin) and its derivatives, but taking a B3 supplement is an indirect and inefficient way to raise NAD+ compared with a precursor or a direct infusion.

The Sensible Starting Point

If persistent fatigue or brain fog is what brought you here, start with a conversation and a proper workup, not with a drip. We spend the first visit on your symptoms, your history, your previous labs and what you have already tried, and we order the tests that make sense for your picture. If NAD+ turns out to be a reasonable part of the plan, we will say so. If something else explains it, we would rather find that.

Your first visit consultation is $35, and that fee applies toward your care.

Call or text (734) 436-3357. Arbour Longevity, 2217 Packard St #15, Ann Arbor, MI 48104. Open Thursday through Monday, 10:00 to 19:00, closed Tuesday and Wednesday. Parking is free and directly outside, with no meters and no structure. Suite 15 is down a flight of stairs, so please call ahead if stairs are difficult for you.

Serving Ann Arbor, Dexter, Saline, Plymouth, Ypsilanti, Canton, Northville and Southeast Michigan.

References

1. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153-160. PMID 31287527. DOI: 10.1001/jama.2019.9052
2. Duralde ER, Sobel TH, Manson JE. Management of perimenopausal and menopausal symptoms. BMJ. 2023;382:e072612. PMID 37553173. DOI: 10.1136/bmj-2022-072612
3. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. PMID 33353981. DOI: 10.1038/s41580-020-00313-x
4. Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 2019;30(4):630-655. PMID 31577933. DOI: 10.1016/j.cmet.2019.09.001
5. Yaku K, Nakagawa T. NAD+ precursors in human health and disease: current status and future prospects. Antioxid Redox Signal. 2023;39(16-18):1133-1149. PMID 37335049. DOI: 10.1089/ars.2023.0354

Citations verified against PubMed. This content is educational and does not constitute medical advice or a promise of any particular result. Individual responses vary.